{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:20:28Z","timestamp":1790266828765,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Agencia Nacional e Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","award":["PICT 2013-1892"],"award-info":[{"award-number":["PICT 2013-1892"]}]},{"name":"Secretar\u00eda de Ciencia y Tecnolog\u00eda, Universidad Nacional de Rosario","award":["1MED410"],"award-info":[{"award-number":["1MED410"]}]},{"name":"Ministerio de Econom\u00eda y competitividad and Fondo Europeo de Desarrollo Regional","award":["SAF2016-75988-R (MINECO\/FEDER)"],"award-info":[{"award-number":["SAF2016-75988-R (MINECO\/FEDER)"]}]},{"name":"Ministerio de Econom\u00eda y competitividad and Fondo Europeo de Desarrollo Regional","award":["SAF2015-63868-R (MINECO\/FEDER)"],"award-info":[{"award-number":["SAF2015-63868-R (MINECO\/FEDER)"]}]},{"name":"Red de Investigaci\u00f3n de Centros de Enfermedades Tropicales","award":["RICET RD12\/0018\/0004"],"award-info":[{"award-number":["RICET RD12\/0018\/0004"]}]},{"DOI":"10.13039\/501100006541","name":"Consejer\u00eda de Sanidad, Comunidad de Madrid","doi-asserted-by":"publisher","award":["S-2010\/BMD-2332"],"award-info":[{"award-number":["S-2010\/BMD-2332"]}],"id":[{"id":"10.13039\/501100006541","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades-Agencia Estatal de Investigaci\u00f3n and Fondo Europeo de Desarrollo Regional","award":["PGC2018-096132-B-I00"],"award-info":[{"award-number":["PGC2018-096132-B-I00"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chagas disease affects approximately 7 million people worldwide in Latin America and is a neglected tropical disease. Twenty to thirty percent of chronically infected patients develop chronic Chagas cardiomyopathy decades after acute infection. Identifying biomarkers of Chagas disease progression is necessary to develop better therapeutic and preventive strategies. Circulating microRNAs are increasingly reliable biomarkers of disease and therapeutic targets. To identify new circulating microRNAs for Chagas disease, we performed exploratory small RNA sequencing from the plasma of patients and performed de novo miRNA prediction, identifying potential new microRNAs. The levels of the new microRNAs temporarily named miR-Contig-1519 and miR-Contig-3244 and microRNAs that are biomarkers for nonchagasic cardiomyopathies, such as miR-148a-3p and miR-224-5p, were validated by quantitative reverse transcription. We found a specific circulating microRNA signature defined by low miR-Contig-3244, miR-Contig-1519, and miR-148a-3 levels but high miR-224-5p levels for patients with chronic Chagas disease. Finally, we predicted in silico that these altered circulating microRNAs could affect the expression of target genes involved in different cellular pathways and biological processes, which we will explore in the future.<\/jats:p>","DOI":"10.1038\/s41598-024-51487-9","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T10:02:16Z","timestamp":1705053736000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Discovery of circulating miRNAs as biomarkers of chronic Chagas heart disease via a small RNA-Seq approach"],"prefix":"10.1038","volume":"14","author":[{"given":"Silvina R.","family":"Villar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Herreros-Cabello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Callejas-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda C.","family":"Maza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"del Moral-Salmoral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"G\u00f3mez-Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor O.","family":"Rodr\u00edguez-Angulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"G\u00f3rgolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pau","family":"Bosch-Nicolau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"P\u00e9rez-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Monge-Maillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar A.","family":"Bottasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Beloscar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana R.","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Fresno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Giron\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,12]]},"reference":[{"key":"51487_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","volume":"391","author":"JA P\u00e9rez-Molina","year":"2018","unstructured":"P\u00e9rez-Molina, J. A. & Molina, I. Chagas disease. Lancet 391, 82\u201394 (2018).","journal-title":"Lancet"},{"key":"51487_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S1473-3099(01)00065-2","volume":"1","author":"A Prata","year":"2001","unstructured":"Prata, A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect. Dis. 1, 92\u2013100 (2001).","journal-title":"Lancet Infect. Dis."},{"key":"51487_CR3","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","volume":"375","author":"A Rassi","year":"2010","unstructured":"Rassi, A., Rassi, A. & Marin-Neto, J. A. Chagas disease. Lancet 375, 1388\u20131402 (2010).","journal-title":"Lancet"},{"key":"51487_CR4","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ymeth.2012.09.015","volume":"59","author":"T Blondal","year":"2013","unstructured":"Blondal, T. et al. Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods 59, S1-6 (2013).","journal-title":"Methods"},{"key":"51487_CR5","doi-asserted-by":"publisher","first-page":"e0008889","DOI":"10.1371\/journal.pntd.0008889","volume":"14","author":"L Laugier","year":"2020","unstructured":"Laugier, L. et al. miRNAs may play a major role in the control of gene expression in key pathobiological processes in Chagas disease cardiomyopathy. PLoS Negl. Trop. Dis. 14, e0008889 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"51487_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ceb.2004.04.003","volume":"16","author":"EP Murchison","year":"2004","unstructured":"Murchison, E. P. & Hannon, G. J. miRNAs on the move: miRNA biogenesis and the RNAi machinery. Curr. Opin. Cell Biol. 16, 223\u2013229 (2004).","journal-title":"Curr. Opin. Cell Biol."},{"key":"51487_CR7","doi-asserted-by":"publisher","first-page":"985408","DOI":"10.1155\/2014\/985408","volume":"2014","author":"E Bronze-da-Rocha","year":"2014","unstructured":"Bronze-da-Rocha, E. MicroRNAs expression profiles in cardiovascular diseases. Biomed. Res. Int. 2014, 985408 (2014).","journal-title":"Biomed. Res. Int."},{"key":"51487_CR8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.recesp.2017.02.027","volume":"70","author":"D de Gonzalo-Calvo","year":"2017","unstructured":"de Gonzalo-Calvo, D., Iglesias-Guti\u00e9rrez, E. & Llorente-Cort\u00e9s, V. Epigenetic biomarkers and cardiovascular disease: Circulating MicroRNAs. Rev. Esp. Cardiol. (Engl. Ed.) 70, 763\u2013769 (2017).","journal-title":"Rev. Esp. Cardiol. (Engl. Ed.)"},{"key":"51487_CR9","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1161\/01.RES.0000257913.42552.23","volume":"100","author":"D Sayed","year":"2007","unstructured":"Sayed, D., Hong, C., Chen, I.-Y., Lypowy, J. & Abdellatif, M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ. Res. 100, 416\u2013424 (2007).","journal-title":"Circ. Res."},{"key":"51487_CR10","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s11906-012-0310-7","volume":"14","author":"VPM van Empel","year":"2012","unstructured":"van Empel, V. P. M., De Windt, L. J. & da Costa Martins, P. A. Circulating miRNAs: Reflecting or affecting cardiovascular disease?. Curr. Hypertens. Rep. 14, 498\u2013509 (2012).","journal-title":"Curr. Hypertens. Rep."},{"key":"51487_CR11","doi-asserted-by":"publisher","first-page":"13027","DOI":"10.1073\/pnas.0805038105","volume":"105","author":"E van Rooij","year":"2008","unstructured":"van Rooij, E. et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl. Acad. Sci. U.S.A. 105, 13027\u201313032 (2008).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"51487_CR12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fimmu.2017.00118","volume":"8","author":"CN Correia","year":"2017","unstructured":"Correia, C. N. et al. Circulating microRNAs as potential biomarkers of infectious disease. Front. Immunol. 8, 118 (2017).","journal-title":"Front. Immunol."},{"key":"51487_CR13","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1139\/bcb-2018-0027","volume":"96","author":"C Miao","year":"2018","unstructured":"Miao, C., Chang, J., Zhang, G. & Fang, Y. MicroRNAs in type 1 diabetes: New research progress and potential directions. Biochem. Cell Biol. 96, 498\u2013506 (2018).","journal-title":"Biochem. Cell Biol."},{"key":"51487_CR14","doi-asserted-by":"publisher","first-page":"E2012","DOI":"10.3390\/ijms21062012","volume":"21","author":"C Lopez-Pedrera","year":"2020","unstructured":"Lopez-Pedrera, C. et al. Role of microRNAs in the development of cardiovascular disease in systemic autoimmune disorders. Int. J. Mol. Sci. 21, E2012 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"51487_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.atherosclerosis.2016.09.067","volume":"254","author":"JN Jones Buie","year":"2016","unstructured":"Jones Buie, J. N., Goodwin, A. J., Cook, J. A., Halushka, P. V. & Fan, H. The role of miRNAs in cardiovascular disease risk factors. Atherosclerosis 254, 271\u2013281 (2016).","journal-title":"Atherosclerosis"},{"key":"51487_CR16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/jcmm.12236","volume":"18","author":"L Moldovan","year":"2014","unstructured":"Moldovan, L. et al. Methodological challenges in utilizing miRNAs as circulating biomarkers. J. Cell. Mol. Med. 18, 371\u2013390 (2014).","journal-title":"J. Cell. Mol. Med."},{"key":"51487_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fmicb.2018.00269","volume":"9","author":"L Linhares-Lacerda","year":"2018","unstructured":"Linhares-Lacerda, L. et al. Circulating plasma MicroRNA-208a as potential biomarker of chronic indeterminate phase of Chagas disease. Front. Microbiol. 9, 269 (2018).","journal-title":"Front. Microbiol."},{"key":"51487_CR18","doi-asserted-by":"publisher","first-page":"E4064","DOI":"10.3390\/ijms20164064","volume":"20","author":"CKV Nonaka","year":"2019","unstructured":"Nonaka, C. K. V. et al. Circulating miRNAs as potential biomarkers associated with cardiac remodeling and fibrosis in chagas disease cardiomyopathy. Int. J. Mol. Sci. 20, E4064 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"51487_CR19","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ijcard.2014.05.019","volume":"175","author":"LRP Ferreira","year":"2014","unstructured":"Ferreira, L. R. P. et al. MicroRNAs miR-1, miR-133a, miR-133b, miR-208a and miR-208b are dysregulated in chronic Chagas disease cardiomyopathy. Int. J. Cardiol. 175, 409\u2013417 (2014).","journal-title":"Int. J. Cardiol."},{"key":"51487_CR20","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nbt1394","volume":"26","author":"MR Friedl\u00e4nder","year":"2008","unstructured":"Friedl\u00e4nder, M. R. et al. Discovering microRNAs from deep sequencing data using miRDeep. Nat. Biotechnol. 26, 407\u2013415 (2008).","journal-title":"Nat. Biotechnol."},{"key":"51487_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00402","author":"J O\u2019Brien","year":"2018","unstructured":"O\u2019Brien, J., Hayder, H., Zayed, Y. & Peng, C. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front. Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2018.00402 (2018).","journal-title":"Front. Endocrinol."},{"key":"51487_CR22","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90-97 (2016).","journal-title":"Nucleic Acids Res."},{"key":"51487_CR23","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie, Z. et al. Gene set knowledge discovery with Enrichr. Curr. Protoc. 1, e90 (2021).","journal-title":"Curr. Protoc."},{"key":"51487_CR24","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3389\/fphar.2019.00445","volume":"10","author":"R Huang","year":"2019","unstructured":"Huang, R. et al. The NCATS BioPlanet\u2014An integrated platform for exploring the universe of cellular signaling pathways for toxicology, systems biology, and chemical genomics. Front. Pharmacol. 10, 445 (2019).","journal-title":"Front. Pharmacol."},{"key":"51487_CR25","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/nar\/gkab102","volume":"49","author":"W Gao","year":"2021","unstructured":"Gao, W. et al. Multiplex indexing approach for the detection of DNase I hypersensitive sites in single cells. Nucleic Acids Res. 49, e56 (2021).","journal-title":"Nucleic Acids Res."},{"key":"51487_CR26","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1096\/fj.14-257808","volume":"29","author":"V Patel","year":"2015","unstructured":"Patel, V. et al. The stretch responsive microRNA miR-148a-3p is a novel repressor of IKBKB, NF-\u03baB signaling, and inflammatory gene expression in human aortic valve cells. FASEB J. 29, 1859\u20131868 (2015).","journal-title":"FASEB J."},{"key":"51487_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2021.4985","volume":"48","author":"F Wang","year":"2021","unstructured":"Wang, F. et al. KLF5\/LINC00346\/miR-148a-3p axis regulates inflammation and endothelial cell injury in atherosclerosis. Int. J. Mol. Med. 48, 1\u201310 (2021).","journal-title":"Int. J. Mol. Med."},{"key":"51487_CR28","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.ijpara.2019.08.002","volume":"49","author":"BR Giri","year":"2019","unstructured":"Giri, B. R. & Cheng, G. Host miR-148 regulates a macrophage-mediated immune response during Schistosoma japonicum infection. Int. J. Parasitol. 49, 993\u2013997 (2019).","journal-title":"Int. J. Parasitol."},{"key":"51487_CR29","doi-asserted-by":"publisher","first-page":"C206","DOI":"10.1152\/ajpcell.00282.2003","volume":"286","author":"MP Aoki","year":"2004","unstructured":"Aoki, M. P. et al. Cruzipain, a major Trypanosoma cruzi antigen, promotes arginase-2 expression and survival of neonatal mouse cardiomyocytes. Am. J. Physiol. Cell Physiol. 286, C206-212 (2004).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"51487_CR30","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.3389\/fimmu.2017.01327","volume":"8","author":"F Huang","year":"2017","unstructured":"Huang, F. et al. miR-148a-3p mediates notch signaling to promote the differentiation and M1 activation of macrophages. Front. Immunol. 8, 1327 (2017).","journal-title":"Front. Immunol."},{"key":"51487_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1538\/expanim.19-0058","volume":"69","author":"Y Cheng","year":"2020","unstructured":"Cheng, Y. et al. Inhibition of long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 attenuates high glucose-induced cardiomyocyte apoptosis via regulation of miR-181a-5p. Exp. Anim. 69, 34\u201344 (2020).","journal-title":"Exp. Anim."},{"key":"51487_CR32","doi-asserted-by":"publisher","first-page":"108916","DOI":"10.1016\/j.abb.2021.108916","volume":"705","author":"C Zhai","year":"2021","unstructured":"Zhai, C. et al. LncRNA AK087124\/miR-224-5p\/PTEN axis modulates endothelial cell injury in atherosclerosis through apoptosis and AKT signaling pathway. Arch. Biochem. Biophys. 705, 108916 (2021).","journal-title":"Arch. Biochem. Biophys."},{"key":"51487_CR33","doi-asserted-by":"publisher","first-page":"656093","DOI":"10.3389\/fcvm.2021.656093","volume":"8","author":"H Zheng","year":"2021","unstructured":"Zheng, H., Shi, L., Tong, C., Liu, Y. & Hou, M. circSnx12 is involved in ferroptosis during heart failure by targeting miR-224-5p. Front. Cardiovasc. Med. 8, 656093 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"51487_CR34","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3390\/genes14030632","volume":"14","author":"T Levstek","year":"2023","unstructured":"Levstek, T., Karun, T., Rehberger Likozar, A., \u0160ebe\u0161tjen, M. & Trebu\u0161ak Podkraj\u0161ek, K. Interplay between microRNAs, serum proprotein convertase subtilisin\/kexin type 9 (PCSK9), and lipid parameters in patients with very high lipoprotein(a) treated with PCSK9 inhibitors. Genes (Basel) 14, 632 (2023).","journal-title":"Genes (Basel)"},{"key":"51487_CR35","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12872-022-02756-w","volume":"22","author":"K James","year":"2022","unstructured":"James, K. et al. Increased expression of miR-224-5p in circulating extracellular vesicles of patients with reduced coronary flow reserve. BMC Cardiovasc. Disord. 22, 321 (2022).","journal-title":"BMC Cardiovasc. Disord."},{"key":"51487_CR36","doi-asserted-by":"publisher","first-page":"5353","DOI":"10.1093\/emboj\/16.17.5353","volume":"16","author":"A Nakao","year":"1997","unstructured":"Nakao, A. et al. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J. 16, 5353\u20135362 (1997).","journal-title":"EMBO J."},{"key":"51487_CR37","doi-asserted-by":"publisher","first-page":"767576","DOI":"10.3389\/fcimb.2021.767576","volume":"11","author":"RR Ferreira","year":"2021","unstructured":"Ferreira, R. R. et al. The search for biomarkers and treatments in Chagas disease: Insights from TGF-beta studies and immunogenetics. Front. Cell. Infect. Microbiol. 11, 767576 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"51487_CR38","doi-asserted-by":"publisher","first-page":"e210395","DOI":"10.1590\/0074-02760210395","volume":"117","author":"MC Waghabi","year":"2022","unstructured":"Waghabi, M. C. et al. Transforming growth factor-\u00df as a therapeutic target for the cardiac damage of Chagas disease. Mem. Inst. Oswaldo Cruz 117, e210395 (2022).","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"51487_CR39","doi-asserted-by":"publisher","first-page":"1017040","DOI":"10.3389\/fcimb.2022.1017040","volume":"12","author":"RR Ferreira","year":"2022","unstructured":"Ferreira, R. R. et al. In Chagas disease, transforming growth factor beta neutralization reduces Trypanosoma cruzi infection and improves cardiac performance. Front. Cell. Infect. Microbiol. 12, 1017040 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"51487_CR40","doi-asserted-by":"publisher","first-page":"674078","DOI":"10.3389\/fimmu.2021.674078","volume":"12","author":"F Ferragut","year":"2021","unstructured":"Ferragut, F., Acevedo, G. R. & G\u00f3mez, K. A. T cell specificity: A great challenge in Chagas disease. Front. Immunol. 12, 674078 (2021).","journal-title":"Front. Immunol."},{"key":"51487_CR41","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.3389\/fimmu.2018.01929","volume":"9","author":"GR Acevedo","year":"2018","unstructured":"Acevedo, G. R., Girard, M. C. & G\u00f3mez, K. A. The unsolved Jigsaw puzzle of the immune response in Chagas disease. Front. Immunol. 9, 1929 (2018).","journal-title":"Front. Immunol."},{"key":"51487_CR42","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1086\/529527","volume":"197","author":"H Cuervo","year":"2008","unstructured":"Cuervo, H. et al. Inducible nitric oxide synthase and arginase expression in heart tissue during acute Trypanosoma cruzi infection in mice: Arginase I is expressed in infiltrating CD68+ macrophages. J. Infect. Dis. 197, 1772\u20131782 (2008).","journal-title":"J. Infect. Dis."},{"key":"51487_CR43","doi-asserted-by":"publisher","first-page":"e0008608","DOI":"10.1371\/journal.pntd.0008608","volume":"14","author":"C Poveda","year":"2020","unstructured":"Poveda, C. et al. Interaction of signaling lymphocytic activation molecule family 1 (SLAMF1) receptor with Trypanosoma cruzi is strain-dependent and affects NADPH oxidase expression and activity. PLoS Negl. Trop. Dis. 14, e0008608 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"51487_CR44","doi-asserted-by":"publisher","first-page":"105057","DOI":"10.1016\/j.actatropica.2019.105057","volume":"199","author":"E Barrias","year":"2019","unstructured":"Barrias, E., Reignault, L., de Carvalho, T. M. U. & de Souza, W. Clathrin coated pit dependent pathway for Trypanosoma cruzi internalization into host cells. Acta Trop. 199, 105057 (2019).","journal-title":"Acta Trop."},{"key":"51487_CR45","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1097\/00001756-200112040-00022","volume":"12","author":"MV Chuenkova","year":"2001","unstructured":"Chuenkova, M. V. & Pereira, M. A. The T. Cruzi trans-sialidase induces PC12 cell differentiation via MAPK\/ERK pathway. Neuroreport 12, 3715\u20133718 (2001).","journal-title":"Neuroreport"},{"key":"51487_CR46","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/cbf.3586","volume":"39","author":"R Lattanzi","year":"2021","unstructured":"Lattanzi, R., Maftei, D., Fullone, M. R. & Miele, R. Trypanosoma cruzi trans-sialidase induces STAT3 and ERK activation by prokineticin receptor 2 binding. Cell Biochem. Funct. 39, 326\u2013334 (2021).","journal-title":"Cell Biochem. Funct."},{"key":"51487_CR47","doi-asserted-by":"publisher","first-page":"e0011191","DOI":"10.1371\/journal.pntd.0011191","volume":"17","author":"G Ferri","year":"2023","unstructured":"Ferri, G., Musikant, D. & Edreira, M. M. Host cell Rap1b mediates cAMP-dependent invasion by Trypanosoma cruzi. PLoS Negl. Trop. Dis. 17, e0011191 (2023).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"51487_CR48","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1128\/IAI.72.9.5274-5282.2004","volume":"72","author":"S Mukherjee","year":"2004","unstructured":"Mukherjee, S. et al. Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells. Infect. Immun. 72, 5274\u20135282 (2004).","journal-title":"Infect. Immun."},{"key":"51487_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40659-021-00345-3","volume":"54","author":"MA Ballinas-Verdugo","year":"2021","unstructured":"Ballinas-Verdugo, M. A. et al. Circulating miR-146a as a possible candidate biomarker in the indeterminate phase of Chagas disease. Biol. Res. 54, 21 (2021).","journal-title":"Biol. Res."},{"key":"51487_CR50","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00948-19","author":"BK Jha","year":"2020","unstructured":"Jha, B. K. et al. MicroRNA-155 deficiency exacerbates Trypanosoma cruzi infection. Infect. Immun. https:\/\/doi.org\/10.1128\/IAI.00948-19 (2020).","journal-title":"Infect. Immun."},{"key":"51487_CR51","doi-asserted-by":"publisher","first-page":"595250","DOI":"10.3389\/fimmu.2020.595250","volume":"11","author":"L Medina","year":"2020","unstructured":"Medina, L. et al. Trypanosoma cruzi and Toxoplasma gondii induce a differential MicroRNA profile in human placental explants. Front. Immunol. 11, 595250 (2020).","journal-title":"Front. Immunol."},{"key":"51487_CR52","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/s41598-022-05493-4","volume":"12","author":"PSG Farani","year":"2022","unstructured":"Farani, P. S. G., Ferreira, B. I. S., Gibaldi, D., Lannes-Vieira, J. & Moreira, O. C. Modulation of miR-145-5p and miR-146b-5p levels is linked to reduced parasite load in H9C2 Trypanosoma cruzi infected cardiomyoblasts. Sci. Rep. 12, 1436 (2022).","journal-title":"Sci. Rep."},{"key":"51487_CR53","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12967-016-0893-x","volume":"14","author":"LF Gulyaeva","year":"2016","unstructured":"Gulyaeva, L. F. & Kushlinskiy, N. E. Regulatory mechanisms of microRNA expression. J. Transl. Med. 14, 143 (2016).","journal-title":"J. Transl. Med."},{"key":"51487_CR54","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3892\/ol.2016.5452","volume":"13","author":"S Pizzamiglio","year":"2017","unstructured":"Pizzamiglio, S. et al. A methodological procedure for evaluating the impact of hemolysis on circulating microRNAs. Oncol. Lett. 13, 315\u2013320 (2017).","journal-title":"Oncol. Lett."},{"key":"51487_CR55","first-page":"94","volume":"4","author":"MB Kirschner","year":"2013","unstructured":"Kirschner, M. B. et al. The impact of hemolysis on cell-free microRNA biomarkers. Front. Genet. 4, 94 (2013).","journal-title":"Front. Genet."},{"key":"51487_CR56","unstructured":"A Quick-Reference Tool for Hemolysis Status | Division of Vector-Borne Diseases | NCEZID | CDC. https:\/\/www.cdc.gov\/ncezid\/dvbd\/specimensub\/hemolysis-palette.html (2023)."},{"key":"51487_CR57","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"51487_CR58","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/nar\/gkr688","volume":"40","author":"MR Friedl\u00e4nder","year":"2012","unstructured":"Friedl\u00e4nder, M. R., Mackowiak, S. D., Li, N., Chen, W. & Rajewsky, N. miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res. 40, 37\u201352 (2012).","journal-title":"Nucleic Acids Res."},{"key":"51487_CR59","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen, Y. & Wang, X. miRDB: An online database for prediction of functional microRNA targets. Nucleic Acids Res. 48, D127\u2013D131 (2020).","journal-title":"Nucleic Acids Res."},{"key":"51487_CR60","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13059-019-1629-z","volume":"20","author":"W Liu","year":"2019","unstructured":"Liu, W. & Wang, X. Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data. Genome Biol. 20, 18 (2019).","journal-title":"Genome Biol."}],"updated-by":[{"DOI":"10.1038\/s41598-024-69310-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-51487-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-51487-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-51487-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T15:08:49Z","timestamp":1723216129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-51487-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,12]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["51487"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-51487-9","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-024-69310-w","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,12]]},"assertion":[{"value":"20 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-024-69310-w","URL":"https:\/\/doi.org\/10.1038\/s41598-024-69310-w","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1187"}}